Literature DB >> 8631977

The IgG binding site of human FcgammaRIIIB receptor involves CC' and FG loops of the membrane-proximal domain.

A Tamm1, A Kister, K U Nolte, J E Gessner, R E Schmidt.   

Abstract

Fc gamma receptors for the Fc part of IgG are the mediators for antibody effector functions. FcgammaRIII and FcgammaRII are low affinity receptors that, through the interaction with immune complexes, initiate a variety of immunological responses, such as phagocytosis, antibody-dependent cellular cytotoxicity, and release of inflammatory mediators. We set out to define the IgG binding site on human FcgammaRIII. We assumed that potential beta-turns in Ig-like domains are the most probable determinants for ligand binding, and chimeric FcgammaRIIIB/FcepsilonRI receptors as well as single residue mutants were constructed in these regions of FcgammaRIIIB. Substitution of four amino acids in the membrane-proximal domain (Gln126, Arg156, Lys162, Val164) resulted in decreased binding of human IgG1. Lys162 and Val164 were found also to be crucial for the interaction with the IgG-binding inhibitory monoclonal antibody 3G8. In a putative three-dimensional model constructed in this study, these residues map on the CC loop (Gln126), on F beta-sheet (Arg156), and on the FG loop (Lys162, Val164). Our data are consistent with the study about human FcgammaRII (Hulett, M. D., Witort, E., Brinkworth, R. I., McKenzie, I. F. C., and Hogarth, P. M. (1994) J. Biol. Chem. 269, 15287-15293), suggesting that common structural determinants, i.e. FG loop or the GFC surface of the membrane-proximal domain, can be involved in interactions with IgG by both low affinity receptor classes FcgammaRII and FcgammaRIII.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631977     DOI: 10.1074/jbc.271.7.3659

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.

Authors:  J Wu; J C Edberg; P B Redecha; V Bansal; P M Guyre; K Coleman; J E Salmon; R P Kimberly
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 2.  Structure and function of natural-killer-cell receptors.

Authors:  Peter D Sun
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

3.  Differential inhibition of trastuzumab- and cetuximab-induced cytotoxicity of cancer cells by immunoglobulin G1 expressing different GM allotypes.

Authors:  A M Namboodiri; J P Pandey
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

4.  The high-affinity Fc gamma RI on PMN: regulation of expression and signal transduction.

Authors:  F Hoffmeyer; K Witte; R E Schmidt
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

Review 5.  Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity?

Authors:  Randall J Brezski; Robert E Jordan
Journal:  MAbs       Date:  2010-05-23       Impact factor: 5.857

6.  Glycosylation of FcgammaRIII in N163 as mechanism of regulating receptor affinity.

Authors:  Bettina Drescher; Torsten Witte; Reinhold E Schmidt
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

7.  Tumor-associated and microbial proteases compromise host IgG effector functions by a single cleavage proximal to the hinge.

Authors:  Randall J Brezski; Omid Vafa; Diane Petrone; Susan H Tam; Gordon Powers; Mary H Ryan; Jennifer L Luongo; Allison Oberholtzer; David M Knight; Robert E Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

8.  Engineered protease-resistant antibodies with selectable cell-killing functions.

Authors:  Michelle Kinder; Allison R Greenplate; Katharine D Grugan; Keri L Soring; Katharine A Heeringa; Stephen G McCarthy; Gregory Bannish; Meredith Perpetua; Frank Lynch; Robert E Jordan; William R Strohl; Randall J Brezski
Journal:  J Biol Chem       Date:  2013-08-28       Impact factor: 5.157

9.  Limited role of charge matching in the interaction of human immunoglobulin A with the immunoglobulin A Fc receptor (Fc alpha RI) CD89.

Authors:  Richard J Pleass; Prabhjyot K Dehal; Melanie J Lewis; Jenny M Woof
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

10.  Immunoglobulin-binding sites of human FcalphaRI (CD89) and bovine Fcgamma2R are located in their membrane-distal extracellular domains.

Authors:  H C Morton; G van Zandbergen; C van Kooten; C J Howard; J G van de Winkel; P Brandtzaeg
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.